SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 4

Evaluation of the Effect of Type 1 and Type 2Diabetes Mellitus without Diabetic Retinopathy onSubfoveal Choroidal Thickness and Central MacularThickness in Adolescents

Hamdi Cihan EMEKSİZ
Halit Oğuz
Merve Nur HEPOKUR
Mustafa HEPOKUR
Ayşe AŞIK
Pages
379–384
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Largerseries and further studies are needed to better demonstrate this different effect on choroidal layer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Evaluation of the effect of Type 1 and Type 2 diabetes mellitus (DM) without diabetic retinopathy on subfovealchoroidal thickness (SCT) and central macular thickness (CMT) in adolescents.
📊
Key Findings & Data:Materials and Methods: This prospective cohort study included a total of 70 eyes of 35 patients and 42 eyes of 21 age matched healthy control individuals.
💡
Conclusion & Impact:Largerseries and further studies are needed to better demonstrate this different effect on choroidal layer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Evaluation of the effect of Type 1 and Type 2 diabetes mellitus (DM) without diabetic retinopathy on subfovealchoroidal thickness (SCT) and central macular thickness (CMT) in adolescents. Materials and Methods: This prospective cohort study included a total of 70 eyes of 35 patients and 42 eyes of 21 age matched healthy control individuals. SCT and CMT were measured in all participants using enhanced depth imaging-opticalcoherence tomography. Results: Forty eyes of 20 patients with Type 1 DM, 30 eyes of 15 patients with Type 2 DM and 42 eyes of 21 healthycontrols were examined. SCT was significantly lower in type 1 DM group than in type 2 DM group (p=0.008). CMT didnot significantly differ among the three groups (p=0.412). SCT and CMT did not correlate with HbA1c, BMI, fasting bloodglucose, HDL, LDL, total cholesterol and triglycerides levels and also duration of diabetes. Conclusion: We revealed that the SCT was significantly thinner in Type 1 diabetic adolescents than type 2 DM. Largerseries and further studies are needed to better demonstrate this different effect on choroidal layer.

🔖

Cite This Article

EMEKSİZ, H. C., Oğuz, H., HEPOKUR, M. N., HEPOKUR, M., AŞIK, A. (2022). Evaluation of the Effect of Type 1 and Type 2Diabetes Mellitus without Diabetic Retinopathy onSubfoveal Choroidal Thickness and Central MacularThickness in Adolescents. Erciyes Medical Journal, Cilt: 43 - Sayı: 4, 379–384. https://ajindex.com/articles/502285

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Norris AW, Wolfsdorf JI. Diabetes mellitus. In: Brook GD, Clayton PE, Brown RS, Savage MO, editors. Clinical Pediatric Endocrinology. 5th ed. Massachusetts, USA: Blackwell Publishing Ltd.; 2005. p. 436–91
  2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl 1): S62–9
  3. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007; 14(4): 179–83
  4. Antonetti DA, Lieth E, Barber AJ, Gardner TW. Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol 1999; 14(4): 240–8
  5. Bresnick GH. Diabetic macular edema. A review. Ophthalmology 1986; 93(7): 989–97
  6. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, et al. Diabetic retinopathy. Diabetes Care 1998; 21(1): 143–56
  7. Lutty GA, Cao J, McLeod DS. Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 1997; 151(3): 707–14
  8. Hidayat AA, Fine BS. Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology 1985; 92(4): 512–22
  9. Weinberger D, Kramer M, Priel E, Gaton DD, Axer-Siegel R, Yassur Y. Indocyanine green angiographic findings in non proliferative diabetic retinopathy. Am J Ophthalmol 1998; 126(2): 238–47
  10. Coleman DJ, Silverman RH, Chabi A, Rondeau MJ, Shung KK, Cannata J, et al. High-resolution ultrasonic imaging of the posterior segment. Ophthalmology 2004; 111(7): 1344–51
  11. Mrejen S, Spaide RF. Optical coherence tomography: İmaging of the choroid and beyond. Surv Ophthalmol 2013; 58(5): 387–429
  12. Esmaeelpour M, Brunner S, Ansari-Shahrezaei S, Nemetz S, Povazay B, Kajic V, et al. Choroidal thinning in diabetes Type 1 detected by 3-dimensional 1060 nm optical coherence tomography. Investig Ophthalmol Visual Sci 2012; 53(11): 6803–9
  13. Wakatsuki Y, Shinojima A, Kawamura A, Yuzawa M. Correlation of aging and segmental choroidal thickness measurement using swept source optical coherence tomography in healthy eyes. PLoS One 2015; 10(12): e0144156
  14. Ferreira JT, Vicente A, Proença R, Santos BO, Cunha JP, Alves M, et al. Choroidal thickness in diabetic patients without diabetic retinopathy. Retina 2018; 38(4): 795–804
  15. Querques G, Lattanzio R, Querques L, Del Turco C, Forte R, Pierro L, et al. Enhanced depth imaging optical coherence tomography in Type 2 diabetes. Invest Ophthalmol Vis Sci 2012; 53(10): 6017–24
  16. Yilmaz I, Ozka